The CHA2DS2-VASc score, which adds age 65-74 years, vascular disease and female gender as stroke risk factors to the CHADS2 score, has been put forward to improve risk stratification in patients ...

Dr Patel reviews a study, published in the Annals of Emergency Medicine, that examined the relationship between CHA2DS2-VASc scores and major bleeding in atrial fibrillation patients on rivaroxaban.

The CHA₂DS₂-VASc score, a widely used tool for assessing stroke risk in AF patients, assigns a point for female sex, categorizing women as higher risk compared to men with the same clinical profile.

A CHA2DS2-VASc score of 0 identifies a subgroup of patients with very low stroke risk unlikely to benefit from anticoagulation treatment in contrast. Professor Nabauer said: "AF is the most ...

Recently endorsed by both the ESC and HRS, the CHA2DS2-VASc scoring system is more precisely predictive of stroke risk—compared with the older CHADS2 score—for patients with nonvalvular atrial ...

The CHA2DS2-VASc score is an easy-to-use international guideline to determine a patient's need for blood thinners. Points are added based on age, sex, history of stroke, hypertension, heart ...

Doctors know patients with atrial fibrillation are at a higher risk of having a stroke, and now a new study finds that integrating two separate clinical risk score models helps clinicians more ...

A change isn’t warranted to the CHA2DS2-VASc score as currently structured because it could lead to confusion and impede recent progress that has been made in getting patients with newly diagnosed ...

However, by combining a patient's traditional risk score, known as CHA2DS2-VASc, with the Intermountain Mortality Risk Score (IMRS), physicians and patients are better equipped to evaluate a ...

With more contemporary data, the female-male difference in stroke risk is less evident, hence a non-sex CHA2DS2-VASc score (i.e., CHA2DS2-VASc) may offer better simplicity and practicality for ...

Two new retrospective subanalyses of the RE-LY® trial, involving Pradaxa® (dabigatran etexilate mesylate) capsules, suggested that the reduction in stroke risk achieved with PRADAXA ...